In-hospital switching from clopidogrel to prasugrel following thrombolysis for ST-elevation myocardial infarction: a 3-year single center experience.

about

In-hospital switching from clopidogrel to prasugrel following thrombolysis for ST-elevation myocardial infarction: a 3-year single center experience.

Item

http://www.wikidata.org/entity/Q41025465

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

In-hospital switching from clo ...... year single center experience.

@en

type

Item

label

In-hospital switching from clo ...... year single center experience.

@en

prefLabel

In-hospital switching from clo ...... year single center experience.

@en

P1476

In-hospital switching from clo ...... year single center experience.

@en

P2093

Avi Shimony

http://www.w3.org/2001/XMLSchema#string

Doron Zahger

http://www.w3.org/2001/XMLSchema#string

Harel Gilutz

http://www.w3.org/2001/XMLSchema#string

Jacob Arad

http://www.w3.org/2001/XMLSchema#string

Olga Reitblat

http://www.w3.org/2001/XMLSchema#string

Tsahi T Lerman

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

P304

271-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2048872615584075

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25904758

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

clopidogrel